Nationwide, an estimated 1.2 million people are eligible to receive medication that can prevent the spread of life-threatening HIV infection. But only roughly a third of those eligible are currently ...

CVS is now covering long-acting injectable PrEP, representing a shift from last year when the pharmacy giant announced it was ...

After nearly a decade of working as an advocate for HIV and AIDS treatment, Michael Chancley said he came to a sobering realization. “Seeing that people who look like me, who hang out at the same ...

In this interview, Emma Kaplan-Lewis, M.D., clinical quality director for HIV, hepatitis and sexual health services at NYC ...

The U.S. Food and Drug Administration has approved a highly effective HIV prevention drug that outperforms oral medications in stopping HIV transmission. Developed by Gilead Sciences, the drug ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday ...

Add Yahoo as a preferred source to see more of our stories on Google. Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or ...

The proposed policy could help stem the spread of the virus. This is a KFF Health News story. A proposed federal policy aims to protect older Americans from contracting HIV by offering free preventive ...

In June, Gilead Sciences announced impressive early results from its PURPOSE 1 trial, which showed 100 percent efficacy of lenacapavir in preventing new HIV infections among cisgender women in ...